
business
Malin-backed US drug firm tipped for €1bn sale
US drug development firm Poseida Therapeutics - of which State-backed investor Malin owns approximately 25% - has been tipped by analysts to fetch €1bn by way of a takeover next year.
A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC